Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2024-01-03 00:00:00 ET · period of report 2023-12-29 · accession 0001437749-24-000439 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-03 | 2023-12-29 | BKYI | DEPASQUALE MICHAEL W | CEO, Dir, COB | A - Grant | $2.55 | +139 | 15.2K | +0.9% | +$354.45 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-29 | A | A | 139 | $2.55 | 15,241 | D | — | — | (F2) All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023.Holdings do not include options to purchase 2201 shares. |